← Open Payments lookup

KATIE GERVASINI: Open Payments

NPI 1952054496 · SOUTH KINGSTOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$718 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $272 · 2025 $718

Food & beverage: $718
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$210
QOL Medical, LLC5$144
Takeda Pharmaceuticals U.S.A., Inc.4$109
Janssen Biotech, Inc.3$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$73
Ardelyx, Inc.2$49
Lilly USA, LLC1$28
ABBVIE INC.1$27

Products named: REZDIFFRA, Sucraid, TREMFYA, ENTYVIO, XIFAXAN, IBSRELA, GATTEX, OMVOH.

Industry payments across RI — which companies pay providers there.